Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News ESC 2017

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Shelley Wood

August 27, 2017

Presentation ESC 2017

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presenter: David Erlinge

August 27, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

Presentation TCT 2013

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Presenter: Bo Lagerqvist

October 28, 2013

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

What’s Going to Be Hot at TCT 2025

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Observational Study Supports Continuing Oral Anticoagulation During PCI

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content